Nikhil Lalwani, PRESIDENT & CEO at ANI PHARMACEUTICALS INC (ANIP), sold 107,574 shares at $67.13 ($7.1M) on 2024-03-08, disclosed to the SEC on 2024-03-08.
Seasonal sale ($7.1M) by PRESIDENT & CEO — this insider has traded ANIP in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.52 | 28,965 | $1.9M | 26.7% |
| 2 | $65.52 | 28,965 | $1.9M | 26.7% |
| 3 | $66.71 | 17,060 | $1.1M | 16.0% |
| 4 | $67.13 | 16,292 | $1.1M | 15.4% |
| 5 | $67.13 | 16,292 | $1.1M | 15.4% |
| Total | $66.20 avg | 107,574 |
| $7.1M |
| 100% |
| Filing → |
| ANIP | SELL | 2026-08-26 | $401K | — | Filing → |
| ANIP | SELL | 2026-05-13 | $4.3M | — | Filing → |
| ANIP | SELL | 2025-08-14 | $9.8M | — | Filing → |